Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
PHILADELPHIA, April 22, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced
Analysts' Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)
Canaccord Genuity Reiterates Buy on Passage Bio, Maintains $14 Price Target
Canaccord Genuity analyst Whitney Ijem reiterates Passage Bio with a Buy and maintains $14 price target.
Passage Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/05/2024 723.53% Canaccord Genuity → $14 Reiterates Buy → Buy 11/14/2023 194.12% Raymond James $9 → $5 M
New Innovation / R&D Risk for Passage Bio, Inc. – What's the Latest?
Passage Bio Files for $200M Mixed Shelf Offering
Passage Bio GAAP EPS of -$1.86 Beats by $0.04
Passage Bio Tapped Kathleen Borthwick as CFO, Effective March 1
Appointed Kathleen Borthwick as Chief Financial Officer, effective March 1, 2024: Ms. Borthwick previously served as the company's Senior Vice President, Finance and Interim CFO and brings 25 years of
Passage Bio: Runway To Fund Operations Into 4Q 2025 >PASG
Passage Bio: Runway To Fund Operations Into 4Q 2025 >PASG
Passage Bio 4Q Loss/Shr 30c >PASG
Passage Bio 4Q Loss/Shr 30c >PASG
Passage Bio to Participate in Upcoming Investor Conferences
PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersInspire Veterinary (NASDAQ:IVP) stock moved upwards by 178.9% to $0.52 during Friday's pre-market session. The company's market cap stands at $5.7 million. Aclarion (NASDAQ:ACON) stock increase
12 Health Care Stocks Moving In Monday's After-Market Session
GainersCadrenal Therapeutics (NASDAQ:CVKD) shares moved upwards by 8.5% to $1.15 during Monday's after-market session. The market value of their outstanding shares is at $14.9 million. vTv Therapeutic
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTalphera (NASDAQ:TLPH) stock moved upwards by 10.5% to $0.85 during Wednesday's after-market session. The company's market cap stands at $14.4 million. Windtree Therapeutics (NASDAQ:WINT) share
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersAclarion (NASDAQ:ACON) shares rose 70.0% to $0.49 during Thursday's pre-market session. The market value of their outstanding shares is at $4.6 million. TRACON Pharma (NASDAQ:TCON) shares moved
Passage Bio Says Data From Phase 1/2 Trial of Dementia Therapy Exceeded Expectations
Passage Bio (PASG) said Wednesday data from the phase 1/2 trial evaluating PBFT02, a therapy for the treatment of dementia, exceeded expectations, prompting the company to explore the potential for us
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), OrganiGram Holdings (OGI) and Passage Bio (PASG)
Passage Bio Stock Climbs 9% on Dementia Study, Program Update
No Data